PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,832,222 | -13.0% | 1,734,037 | 0.0% | 0.09% | -13.3% |
| Q1 2023 | $4,404,454 | +35.8% | 1,734,037 | 0.0% | 0.10% | +34.6% |
| Q4 2022 | $3,242,649 | -27.2% | 1,734,037 | 0.0% | 0.08% | -32.2% |
| Q3 2022 | $4,456,000 | +33.1% | 1,734,037 | 0.0% | 0.12% | +18.6% |
| Q2 2022 | $3,347,000 | -34.7% | 1,734,037 | +0.4% | 0.10% | -24.8% |
| Q1 2022 | $5,128,000 | -32.7% | 1,726,637 | +1.7% | 0.13% | -26.7% |
| Q4 2021 | $7,620,000 | -5.8% | 1,697,105 | +1.9% | 0.18% | +3.5% |
| Q3 2021 | $8,092,000 | -28.3% | 1,665,014 | +0.6% | 0.17% | -23.8% |
| Q2 2021 | $11,285,000 | -5.1% | 1,654,714 | -1.8% | 0.22% | -13.9% |
| Q1 2021 | $11,894,000 | +13.1% | 1,684,714 | +0.2% | 0.26% | +16.1% |
| Q4 2020 | $10,521,000 | +16.2% | 1,680,614 | +0.4% | 0.22% | -3.0% |
| Q3 2020 | $9,053,000 | +4.8% | 1,673,414 | +1.1% | 0.23% | -3.0% |
| Q2 2020 | $8,640,000 | +79.7% | 1,655,164 | +8.4% | 0.24% | +19.1% |
| Q1 2020 | $4,808,000 | +218.2% | 1,526,310 | +307.0% | 0.20% | +314.6% |
| Q4 2019 | $1,511,000 | -22.3% | 375,000 | -16.7% | 0.05% | -37.7% |
| Q3 2019 | $1,944,000 | +8.2% | 450,000 | 0.0% | 0.08% | +18.5% |
| Q2 2019 | $1,796,000 | -25.5% | 450,000 | 0.0% | 0.06% | -30.1% |
| Q1 2019 | $2,412,000 | +4.5% | 450,000 | 0.0% | 0.09% | -14.7% |
| Q4 2018 | $2,309,000 | -47.1% | 450,000 | 0.0% | 0.11% | -31.0% |
| Q3 2018 | $4,365,000 | -4.9% | 450,000 | 0.0% | 0.16% | -10.7% |
| Q2 2018 | $4,590,000 | -21.5% | 450,000 | 0.0% | 0.18% | -29.2% |
| Q1 2018 | $5,850,000 | -27.4% | 450,000 | 0.0% | 0.25% | -31.5% |
| Q4 2017 | $8,055,000 | -28.7% | 450,000 | 0.0% | 0.36% | -29.9% |
| Q3 2017 | $11,295,000 | -21.9% | 450,000 | -25.0% | 0.52% | -28.6% |
| Q2 2017 | $14,460,000 | +42.9% | 600,000 | +14.2% | 0.73% | +25.0% |
| Q1 2017 | $10,116,000 | +25.0% | 525,500 | 0.0% | 0.58% | +7.7% |
| Q4 2016 | $8,093,000 | +23.8% | 525,500 | +4.6% | 0.54% | +32.2% |
| Q3 2016 | $6,538,000 | +12.3% | 502,500 | +20.1% | 0.41% | -4.9% |
| Q2 2016 | $5,821,000 | +72.1% | 418,500 | +87.7% | 0.43% | +52.3% |
| Q1 2016 | $3,383,000 | +478.3% | 223,000 | +623.4% | 0.28% | +543.2% |
| Q4 2015 | $585,000 | – | 30,827 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |